+关注
天上掉馅饼
暂无个人介绍
IP属地：北京
59
关注
0
粉丝
6
主题
0
勋章
主贴
热门
天上掉馅饼
2020-12-17
$VESYNC(02148)$
老虎暗盘不给力呀，牛牛都到9了
天上掉馅饼
2020-07-01
牛逼的股到哪都牛逼
$瑞幸咖啡(LK)$
$瑞幸咖啡(LKNCY)$
（手动狗头🐶）
瑞幸咖啡在美国粉单市场直线拉升，涨超30%
天上掉馅饼
2020-07-08
都破发了，还高开
海普瑞今日在港挂牌上市，高开0.33%
天上掉馅饼
2021-06-23
充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖
天上掉馅饼
2020-12-17
$VESYNC(02148)$
加油啊老虎，牛都比你虎猛
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3471266583647097,"uuid":"3471266583647097","gmtCreate":1508172598130,"gmtModify":1624462283809,"name":"天上掉馅饼","pinyin":"tsdxbtianshangdiaoxianbing","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":59,"tweetSize":5,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":6,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":18,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.04.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":121800871,"gmtCreate":1624457738493,"gmtModify":1624457738493,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖","listText":"充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖","text":"充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖","images":[{"img":"https://static.tigerbbs.com/31fbd71eec0d9f4acb5746abf30dfb16","width":"1125","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121800871","isVote":1,"tweetType":1,"viewCount":823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":397355202,"gmtCreate":1608193863006,"gmtModify":1703851675759,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>加油啊老虎，牛都比你虎猛","listText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>加油啊老虎，牛都比你虎猛","text":"$VESYNC(02148)$加油啊老虎，牛都比你虎猛","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/397355202","isVote":1,"tweetType":1,"viewCount":1145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":397359496,"gmtCreate":1608193102615,"gmtModify":1703851666596,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>老虎暗盘不给力呀，牛牛都到9了","listText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>老虎暗盘不给力呀，牛牛都到9了","text":"$VESYNC(02148)$老虎暗盘不给力呀，牛牛都到9了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/397359496","isVote":1,"tweetType":1,"viewCount":1545,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":949378537,"gmtCreate":1594175704529,"gmtModify":1704204231503,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"都破发了，还高开","listText":"都破发了，还高开","text":"都破发了，还高开","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/949378537","repostId":"2049199000","repostType":2,"isVote":1,"tweetType":1,"viewCount":1010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":940027076,"gmtCreate":1593613098295,"gmtModify":1704202584798,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"牛逼的股到哪都牛逼<a href=\"https://laohu8.com/S/LK\">$瑞幸咖啡(LK)$</a><a href=\"https://laohu8.com/S/LKNCY\">$瑞幸咖啡(LKNCY)$</a>（手动狗头🐶）","listText":"牛逼的股到哪都牛逼<a href=\"https://laohu8.com/S/LK\">$瑞幸咖啡(LK)$</a><a href=\"https://laohu8.com/S/LKNCY\">$瑞幸咖啡(LKNCY)$</a>（手动狗头🐶）","text":"牛逼的股到哪都牛逼$瑞幸咖啡(LK)$$瑞幸咖啡(LKNCY)$（手动狗头🐶）","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/940027076","repostId":"1143901475","repostType":4,"isVote":1,"tweetType":1,"viewCount":2649,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":397359496,"gmtCreate":1608193102615,"gmtModify":1703851666596,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>老虎暗盘不给力呀，牛牛都到9了","listText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>老虎暗盘不给力呀，牛牛都到9了","text":"$VESYNC(02148)$老虎暗盘不给力呀，牛牛都到9了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/397359496","isVote":1,"tweetType":1,"viewCount":1545,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":940027076,"gmtCreate":1593613098295,"gmtModify":1704202584798,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"牛逼的股到哪都牛逼<a href=\"https://laohu8.com/S/LK\">$瑞幸咖啡(LK)$</a><a href=\"https://laohu8.com/S/LKNCY\">$瑞幸咖啡(LKNCY)$</a>（手动狗头🐶）","listText":"牛逼的股到哪都牛逼<a href=\"https://laohu8.com/S/LK\">$瑞幸咖啡(LK)$</a><a href=\"https://laohu8.com/S/LKNCY\">$瑞幸咖啡(LKNCY)$</a>（手动狗头🐶）","text":"牛逼的股到哪都牛逼$瑞幸咖啡(LK)$$瑞幸咖啡(LKNCY)$（手动狗头🐶）","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/940027076","repostId":"1143901475","repostType":4,"repost":{"id":"1143901475","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1593611706,"share":"https://www.laohu8.com/m/news/1143901475?lang=&edition=full","pubTime":"2020-07-01 21:55","market":"us","language":"zh","title":"瑞幸咖啡在美国粉单市场直线拉升，涨超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143901475","media":"老虎资讯综合","summary":"7月1日，瑞幸咖啡在美国粉单市场直线拉升，一度涨超30%。瑞幸内部调查证实前CEO参与业绩造假 陆正耀或将被免职7月1日晚间，瑞幸咖啡于其官网上宣称，此前财务造假的内部调查已经基本完成。公告显示，内部","content":"<p>7月1日，<span><a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>在美国粉单市场直线拉升，一度涨超30%。</span></p><p><img src=\"https://static.tigerbbs.com/ad73aca80a472e90db56d96c917547ff\" tg-width=\"1125\" tg-height=\"3332\"></p><p>瑞幸内部调查证实前CEO参与业绩造假 陆正耀或将被免职</p><p>7月1日晚间，瑞幸咖啡于其官网上宣称，此前财务造假的内部调查已经基本完成。</p><p>公告显示，内部调查特别委员会发现，虚假交易始于2019年4月，导致公司2019年净收入虚增约21.2亿元（包括第二季度2.5亿元、第三季度7亿元、第四季度11.7亿元）。</p><p>2019年瑞幸咖啡成本支出虚增13.4亿元（其中第二季度1.5亿元，第三季度5.2亿元，第四季度6.7亿元）。公告表示，如果获得其他相关资料，特别委员会可继续执行某些额外的调查。</p><p>同时，迄今发现的证据显示，该公司前CEO钱治亚、前首席运营官刘剑和向他们汇报的某些员工参与了捏造的交易，支持捏造交易的资金是通过与该公司员工有关联的第三方或关联方流入该公司的。</p><p>依据特别委员会的建议，瑞幸咖啡董事会在此前已经令钱治亚和刘剑辞去了职务，理由是有证据证明他们参与了财务造假。</p><p>此外，董事会建议陆正耀辞去董事长的职务，并将在7月2日的董事会会议上正式审议这一建议。</p><p>瑞幸董事会在公告中称：“关于陆正耀的免职是董事会多数成员的要求，并根据特别委员会的调查结果和建议提出的。”</p><p>特别委员会根据内部调查中确定的文件和其他证据，以及对内部调查中陆正耀合作程度的评估，提出了对其免职的建议。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞幸咖啡在美国粉单市场直线拉升，涨超30%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞幸咖啡在美国粉单市场直线拉升，涨超30%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-07-01 21:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月1日，<span><a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>在美国粉单市场直线拉升，一度涨超30%。</span></p><p><img src=\"https://static.tigerbbs.com/ad73aca80a472e90db56d96c917547ff\" tg-width=\"1125\" tg-height=\"3332\"></p><p>瑞幸内部调查证实前CEO参与业绩造假 陆正耀或将被免职</p><p>7月1日晚间，瑞幸咖啡于其官网上宣称，此前财务造假的内部调查已经基本完成。</p><p>公告显示，内部调查特别委员会发现，虚假交易始于2019年4月，导致公司2019年净收入虚增约21.2亿元（包括第二季度2.5亿元、第三季度7亿元、第四季度11.7亿元）。</p><p>2019年瑞幸咖啡成本支出虚增13.4亿元（其中第二季度1.5亿元，第三季度5.2亿元，第四季度6.7亿元）。公告表示，如果获得其他相关资料，特别委员会可继续执行某些额外的调查。</p><p>同时，迄今发现的证据显示，该公司前CEO钱治亚、前首席运营官刘剑和向他们汇报的某些员工参与了捏造的交易，支持捏造交易的资金是通过与该公司员工有关联的第三方或关联方流入该公司的。</p><p>依据特别委员会的建议，瑞幸咖啡董事会在此前已经令钱治亚和刘剑辞去了职务，理由是有证据证明他们参与了财务造假。</p><p>此外，董事会建议陆正耀辞去董事长的职务，并将在7月2日的董事会会议上正式审议这一建议。</p><p>瑞幸董事会在公告中称：“关于陆正耀的免职是董事会多数成员的要求，并根据特别委员会的调查结果和建议提出的。”</p><p>特别委员会根据内部调查中确定的文件和其他证据，以及对内部调查中陆正耀合作程度的评估，提出了对其免职的建议。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/65c6455ef80d23573ed85d61bbc37d01","relate_stocks":{"LKNCY":"瑞幸咖啡","LK":"瑞幸咖啡"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143901475","content_text":"7月1日，瑞幸咖啡在美国粉单市场直线拉升，一度涨超30%。瑞幸内部调查证实前CEO参与业绩造假 陆正耀或将被免职7月1日晚间，瑞幸咖啡于其官网上宣称，此前财务造假的内部调查已经基本完成。公告显示，内部调查特别委员会发现，虚假交易始于2019年4月，导致公司2019年净收入虚增约21.2亿元（包括第二季度2.5亿元、第三季度7亿元、第四季度11.7亿元）。2019年瑞幸咖啡成本支出虚增13.4亿元（其中第二季度1.5亿元，第三季度5.2亿元，第四季度6.7亿元）。公告表示，如果获得其他相关资料，特别委员会可继续执行某些额外的调查。同时，迄今发现的证据显示，该公司前CEO钱治亚、前首席运营官刘剑和向他们汇报的某些员工参与了捏造的交易，支持捏造交易的资金是通过与该公司员工有关联的第三方或关联方流入该公司的。依据特别委员会的建议，瑞幸咖啡董事会在此前已经令钱治亚和刘剑辞去了职务，理由是有证据证明他们参与了财务造假。此外，董事会建议陆正耀辞去董事长的职务，并将在7月2日的董事会会议上正式审议这一建议。瑞幸董事会在公告中称：“关于陆正耀的免职是董事会多数成员的要求，并根据特别委员会的调查结果和建议提出的。”特别委员会根据内部调查中确定的文件和其他证据，以及对内部调查中陆正耀合作程度的评估，提出了对其免职的建议。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2649,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":949378537,"gmtCreate":1594175704529,"gmtModify":1704204231503,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"都破发了，还高开","listText":"都破发了，还高开","text":"都破发了，还高开","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/949378537","repostId":"2049199000","repostType":2,"repost":{"id":"2049199000","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1594171744,"share":"https://www.laohu8.com/m/news/2049199000?lang=&edition=full","pubTime":"2020-07-08 09:29","market":"sh","language":"zh","title":"海普瑞今日在港挂牌上市，高开0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2049199000","media":"老虎资讯综合","summary":"7月8日讯，海普瑞今日首日上市高开0.33%报18.46港元，盘前成交4.02亿港元，最新总市值408亿港元。该股IPO价格为18.4港元，认购倍数69.21倍。据悉，本次赴港上市，海普瑞得到了Orb","content":"<p>7月8日讯，<span><a href=\"https://laohu8.com/S/09989\">海普瑞</a>今日首日上市高开0.33%报18.46港元，盘前成交4.02亿港元，最新总市值408亿港元。该股IPO价格为18.4港元，认购倍数69.21倍。据悉，本次赴港上市，<a href=\"https://laohu8.com/S/002399\">海普瑞</a>得到了OrbiMed Funds、AVICT、欧万达基金、3W、Anlan Funds等国际化基石投资者的支持，合计认购海普瑞4630.75万发售股份，约8.52亿港元。</span><img src=\"https://static.tigerbbs.com/3aa12685b902c47f628a0c5142dc6462\" tg-width=\"750\" tg-height=\"1582\"></p><p><b>延伸阅读：</b></p><p><b><span>海普瑞赴港上市 开启“A+H”双平台融资新篇章</span></b></p><p>7月7日早间，深圳市<a href=\"https://laohu8.com/S/09989\">海普瑞</a>药业集团股份有限公司(以下简称“海普瑞”，002399.SZ，09989.HK)发布了《关于境外上市外资股（H股）配发结果的公告》。这意味着，海普瑞将于明日（7月8日）正式登陆H股，并将发行2.2亿股，发售价定为每股18.40港元，全球发售所得款项净额约为38.06亿港元。</p><p>据悉，本次赴港上市，海普瑞得到了OrbiMed Funds、AVICT、欧万达基金、3W、Anlan Funds等国际化基石投资者的支持，合计认购海普瑞4630.75万发售股份，约8.52亿港元。同时，对于海普瑞本次招股，参与公开发售的投资者也表现出极大的的热情，认购首日即得到超7.7倍认购，截至6月30日认购结束，海普瑞共录得69.21倍的超额认购。</p><p>H股发行认购火热充分体现了投资者对海普瑞综合实力的认可。据了解，海普瑞是国内肝素产业的领军企业，也是国内为数不多的获得美国FDA和欧盟CEP双认证的制药企业。目前，该公司已经建立起完备的肝素产业价值链，并已成为中国最大、全球第三大依诺肝素钠制剂生产及销售商，在全球依诺肝素市场占据了领先的地位。</p><p>近日，海普瑞Inhixa品牌依诺肝素制剂在瑞士获批上市，这是继2019年该公司在欧洲市场占有率高达17.8%后，进一步推进欧洲市场全覆盖的重要里程碑事件。从全球范围来看，海普瑞的依诺肝素制剂已在35个国家获批，并在19个国家销售。与此同时，该公司有计划地持续扩张全球肝素制剂市场占有率，力争成为全球肝素行业的领导者。</p><p>此外，海普瑞官网消息显示，海普瑞坪山产业园已正式获得EMA批准，成为Inhixa所需依诺肝素钠原料药生产地，待其产能达产后，有望全部投向公司依诺肝素钠制剂的生产和销售，不仅可以为海普瑞实现欧洲全覆盖提供充足的产品保障，也为其实现全球市场扩张的战略提供了产能支持。</p><p>值得一提的是，近期海普瑞的重点创新药品种RVX-208临床试验进程也获得了重大突破性进展，美国FDA已经批准了RVX-208接下来III期关键性的临床试验方案，且新的方案以对公司较有利的方式制定，预计将加速RVX-208未来的商业化进程，有望早日为全球患者带来福音。</p><p>除了RVX-208外，海普瑞还有多个创新药在研，其中，AR-101正处于II期全球试验阶段；AR-301正在开展国际多中心III期临床试验，还获得FDA授予的快速通道审批资格认定及EMA授予的罕用药资格认定；Oregovomab已经完成IIb期临床，即将启动全球III期临床试验，并已获得欧盟EMA和美国FDA孤儿药资格认定，预计将加速该品种的开发和审评，提早进入商业化阶段。</p><p>本次H股上市对海普瑞来讲意义非凡，相信有了充足的资本加持，海普瑞可以进一步深化跨国运营战略，拓展海外市场版图，并借助H股平台扩大国际影响力，树立优秀的国际形象，在不远的未来实现估值与业绩双提升。</p><p><b>原文综合自证券市场周刊</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海普瑞今日在港挂牌上市，高开0.33%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海普瑞今日在港挂牌上市，高开0.33%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-07-08 09:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月8日讯，<span><a href=\"https://laohu8.com/S/09989\">海普瑞</a>今日首日上市高开0.33%报18.46港元，盘前成交4.02亿港元，最新总市值408亿港元。该股IPO价格为18.4港元，认购倍数69.21倍。据悉，本次赴港上市，<a href=\"https://laohu8.com/S/002399\">海普瑞</a>得到了OrbiMed Funds、AVICT、欧万达基金、3W、Anlan Funds等国际化基石投资者的支持，合计认购海普瑞4630.75万发售股份，约8.52亿港元。</span><img src=\"https://static.tigerbbs.com/3aa12685b902c47f628a0c5142dc6462\" tg-width=\"750\" tg-height=\"1582\"></p><p><b>延伸阅读：</b></p><p><b><span>海普瑞赴港上市 开启“A+H”双平台融资新篇章</span></b></p><p>7月7日早间，深圳市<a href=\"https://laohu8.com/S/09989\">海普瑞</a>药业集团股份有限公司(以下简称“海普瑞”，002399.SZ，09989.HK)发布了《关于境外上市外资股（H股）配发结果的公告》。这意味着，海普瑞将于明日（7月8日）正式登陆H股，并将发行2.2亿股，发售价定为每股18.40港元，全球发售所得款项净额约为38.06亿港元。</p><p>据悉，本次赴港上市，海普瑞得到了OrbiMed Funds、AVICT、欧万达基金、3W、Anlan Funds等国际化基石投资者的支持，合计认购海普瑞4630.75万发售股份，约8.52亿港元。同时，对于海普瑞本次招股，参与公开发售的投资者也表现出极大的的热情，认购首日即得到超7.7倍认购，截至6月30日认购结束，海普瑞共录得69.21倍的超额认购。</p><p>H股发行认购火热充分体现了投资者对海普瑞综合实力的认可。据了解，海普瑞是国内肝素产业的领军企业，也是国内为数不多的获得美国FDA和欧盟CEP双认证的制药企业。目前，该公司已经建立起完备的肝素产业价值链，并已成为中国最大、全球第三大依诺肝素钠制剂生产及销售商，在全球依诺肝素市场占据了领先的地位。</p><p>近日，海普瑞Inhixa品牌依诺肝素制剂在瑞士获批上市，这是继2019年该公司在欧洲市场占有率高达17.8%后，进一步推进欧洲市场全覆盖的重要里程碑事件。从全球范围来看，海普瑞的依诺肝素制剂已在35个国家获批，并在19个国家销售。与此同时，该公司有计划地持续扩张全球肝素制剂市场占有率，力争成为全球肝素行业的领导者。</p><p>此外，海普瑞官网消息显示，海普瑞坪山产业园已正式获得EMA批准，成为Inhixa所需依诺肝素钠原料药生产地，待其产能达产后，有望全部投向公司依诺肝素钠制剂的生产和销售，不仅可以为海普瑞实现欧洲全覆盖提供充足的产品保障，也为其实现全球市场扩张的战略提供了产能支持。</p><p>值得一提的是，近期海普瑞的重点创新药品种RVX-208临床试验进程也获得了重大突破性进展，美国FDA已经批准了RVX-208接下来III期关键性的临床试验方案，且新的方案以对公司较有利的方式制定，预计将加速RVX-208未来的商业化进程，有望早日为全球患者带来福音。</p><p>除了RVX-208外，海普瑞还有多个创新药在研，其中，AR-101正处于II期全球试验阶段；AR-301正在开展国际多中心III期临床试验，还获得FDA授予的快速通道审批资格认定及EMA授予的罕用药资格认定；Oregovomab已经完成IIb期临床，即将启动全球III期临床试验，并已获得欧盟EMA和美国FDA孤儿药资格认定，预计将加速该品种的开发和审评，提早进入商业化阶段。</p><p>本次H股上市对海普瑞来讲意义非凡，相信有了充足的资本加持，海普瑞可以进一步深化跨国运营战略，拓展海外市场版图，并借助H股平台扩大国际影响力，树立优秀的国际形象，在不远的未来实现估值与业绩双提升。</p><p><b>原文综合自证券市场周刊</b></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{"09989":"海普瑞","002399":"海普瑞"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2049199000","content_text":"7月8日讯，海普瑞今日首日上市高开0.33%报18.46港元，盘前成交4.02亿港元，最新总市值408亿港元。该股IPO价格为18.4港元，认购倍数69.21倍。据悉，本次赴港上市，海普瑞得到了OrbiMed Funds、AVICT、欧万达基金、3W、Anlan Funds等国际化基石投资者的支持，合计认购海普瑞4630.75万发售股份，约8.52亿港元。延伸阅读：海普瑞赴港上市 开启“A+H”双平台融资新篇章7月7日早间，深圳市海普瑞药业集团股份有限公司(以下简称“海普瑞”，002399.SZ，09989.HK)发布了《关于境外上市外资股（H股）配发结果的公告》。这意味着，海普瑞将于明日（7月8日）正式登陆H股，并将发行2.2亿股，发售价定为每股18.40港元，全球发售所得款项净额约为38.06亿港元。据悉，本次赴港上市，海普瑞得到了OrbiMed Funds、AVICT、欧万达基金、3W、Anlan Funds等国际化基石投资者的支持，合计认购海普瑞4630.75万发售股份，约8.52亿港元。同时，对于海普瑞本次招股，参与公开发售的投资者也表现出极大的的热情，认购首日即得到超7.7倍认购，截至6月30日认购结束，海普瑞共录得69.21倍的超额认购。H股发行认购火热充分体现了投资者对海普瑞综合实力的认可。据了解，海普瑞是国内肝素产业的领军企业，也是国内为数不多的获得美国FDA和欧盟CEP双认证的制药企业。目前，该公司已经建立起完备的肝素产业价值链，并已成为中国最大、全球第三大依诺肝素钠制剂生产及销售商，在全球依诺肝素市场占据了领先的地位。近日，海普瑞Inhixa品牌依诺肝素制剂在瑞士获批上市，这是继2019年该公司在欧洲市场占有率高达17.8%后，进一步推进欧洲市场全覆盖的重要里程碑事件。从全球范围来看，海普瑞的依诺肝素制剂已在35个国家获批，并在19个国家销售。与此同时，该公司有计划地持续扩张全球肝素制剂市场占有率，力争成为全球肝素行业的领导者。此外，海普瑞官网消息显示，海普瑞坪山产业园已正式获得EMA批准，成为Inhixa所需依诺肝素钠原料药生产地，待其产能达产后，有望全部投向公司依诺肝素钠制剂的生产和销售，不仅可以为海普瑞实现欧洲全覆盖提供充足的产品保障，也为其实现全球市场扩张的战略提供了产能支持。值得一提的是，近期海普瑞的重点创新药品种RVX-208临床试验进程也获得了重大突破性进展，美国FDA已经批准了RVX-208接下来III期关键性的临床试验方案，且新的方案以对公司较有利的方式制定，预计将加速RVX-208未来的商业化进程，有望早日为全球患者带来福音。除了RVX-208外，海普瑞还有多个创新药在研，其中，AR-101正处于II期全球试验阶段；AR-301正在开展国际多中心III期临床试验，还获得FDA授予的快速通道审批资格认定及EMA授予的罕用药资格认定；Oregovomab已经完成IIb期临床，即将启动全球III期临床试验，并已获得欧盟EMA和美国FDA孤儿药资格认定，预计将加速该品种的开发和审评，提早进入商业化阶段。本次H股上市对海普瑞来讲意义非凡，相信有了充足的资本加持，海普瑞可以进一步深化跨国运营战略，拓展海外市场版图，并借助H股平台扩大国际影响力，树立优秀的国际形象，在不远的未来实现估值与业绩双提升。原文综合自证券市场周刊","news_type":1},"isVote":1,"tweetType":1,"viewCount":1010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":121800871,"gmtCreate":1624457738493,"gmtModify":1624457738493,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖","listText":"充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖","text":"充值100，结果活动没了，只能参与50的活动了，希望晒单能中奖","images":[{"img":"https://static.tigerbbs.com/31fbd71eec0d9f4acb5746abf30dfb16","width":"1125","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121800871","isVote":1,"tweetType":1,"viewCount":823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":397355202,"gmtCreate":1608193863006,"gmtModify":1703851675759,"author":{"id":"3471266583647097","authorId":"3471266583647097","name":"天上掉馅饼","avatar":"https://static.tigerbbs.com/c74827cf78015b6298855c3df618c32d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>加油啊老虎，牛都比你虎猛","listText":"<a href=\"https://laohu8.com/S/02148\">$VESYNC(02148)$</a>加油啊老虎，牛都比你虎猛","text":"$VESYNC(02148)$加油啊老虎，牛都比你虎猛","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/397355202","isVote":1,"tweetType":1,"viewCount":1145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
